ESC 365 - The combined impact of timing for implantable cardioverter-defibrillator implantation and appropriate ICD therapy on outcomes in hypertrophic cardiomyopathy patients

EHRA Premium Access

The combined impact of timing for implantable cardioverter-defibrillator implantation and appropriate ICD therapy on outcomes in hypertrophic cardiomyopathy patients

Session: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor B. Fu (Beijing, CN)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Bingqi Fu

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing (China)

1 presentation

0 follower

158 more presentations in this session

Impact of ICD and CRT-D implantation on survival in ischemic and non-ischemic cardiomyopathy: a single-center croatian retrospective cohort study and comparative insights with the DANISH trial

Speaker: Assistant Professor M. Puljevic (Zagreb, HR)

Do the longer leadless pacemakers with helix screws affect tricuspid regurgitation after pacemaker implantation?

A large footprint catheter toggling between pulsed field and radiofrequency energy: first clinical experience for ventricular tachycardia ablation

Speaker: Doctor L. Pannone (Brussels, BE)

Impact of temporary epicardial left ventricular pacing in the setting of conduction disturbance on haemodynamic performance after cardiopulmonary bypass, time to retire right ventricular pacing

Speaker: Mr M. Hassan (Wuerzburg, DE)

Ten years experience with epicardial pacemaker implantation concomitant with endocarditis surgery, we should really jump the gun

Speaker: Mr M. Hassan (Wuerzburg, DE)

Access the full session

Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias

Speakers: Doctor B. Fu, Assistant Professor M. Puljevic, Doctor L. Pannone, Mr M. Hassan, Mr M. Hassan

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources